Please login to the form below

Levi Garraway

This page shows the latest Levi Garraway news and features for those working in and with pharma, biotech and healthcare.

Roche reports positive results for drug for relapsing forms of MS

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “I am encouraged by this clinical data for fenebrutinib, which is important news for people living with

Latest news

Roche reports positive phase 3 data for Tecentriq combination in liver cancer

Levi Garraway, chief medical officer and head of global product development, said: “Four out of five people with HCC who receive surgery with curative intent may still see their cancer return.
Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “Today’s committee decision to recognise the potential of this Polivy combination as a first-line treatment
Roche reports positive results for crovalimab as rare blood disease treatment

People with PNH may benefit from more options to achieve robust disease control with less frequent treatment intervals,” said Levi Garraway, Roche’s chief medical officer and head of global product ... We look forward to submitting this data to
Roche’s Polivy recommended by NICE for lymphoma therapy

After more than 20 years with very limited treatment advances, the approval of Polivy plus R-CHP marks a new era for people battling this aggressive disease,” said Levi Garraway,
Genentech reports positive phase 3 data for its Tecentriq combination in liver cancer

Levi Garraway, executive VP, chief medical officer and head of global product development at Roche and Genentech, said: “IMbrave050 is the first phase 3 study to show that a cancer immunotherapy

More from news
Approximately 1 fully matching, plus 63 partially matching documents found.

Latest appointments

Lilly appoints Maura Dickler as VP of late phase oncology development

In her new role at Lilly Oncology she will report to senior vice president, global development and medical affairs Levi Garraway.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer

PMHub

Add my company

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Email:
Password:

Please login to the form below

Levi Garraway

Subscribe to our email news alerts

Quick links